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Introduction
Acute kidney injury (AKI) affects 4%–20% of hospitalized patients in the US (1, 2), including up to 50% of  
patients in the intensive care unit (3), and it is associated with a mortality rate approaching 60% (4–6). More-
over, AKI is a predictive factor for end-stage renal disease (ESRD), especially among patients who experience 
multiple ischemic injuries (7). Ischemia-reperfusion injury (IRI) is the culprit behind nearly half  of  the cases 
of  AKI (8). However, experimental studies exploring the roles of  innate and adaptive immunity in ischemic 
AKI have focused mostly on the kidney itself  (9).
The lymph node (LN) is a critical site for immune activation, and it is central to the pathogenesis of  
antigen-specific immunity (10). The function of  the LN is dependent on its specific microvascular, microar-
chitectural, and cellular compartments, which together support the processes of  antigen recognition and 
recruitment of  immune cells from the circulation (11). During normal immune surveillance, naive T cells 
home to the LN via high endothelial venules (HEVs) several times a day, surveying for the presence of  anti-
gens (12). HEVs are located in the paracortical T cell zone of  the LN and surrounded by layers of  fibroblas-
tic reticular cells (FRCs), which form 3-dimensional conduits through which T cells can migrate (13–15).
FRCs, identified both by the expression of  podoplanin (PDPN) and the absence of  endothelial and leu-
kocyte markers, are fibroblast-like cells of  mesodermal origin that reside in the interstitium of the LN. FRCs 
play a critical role in the trafficking of  naive T cells into the LN by secreting chemokines, such as CCL19 and 
CCL21 (16–21). In addition, FRCs produce a highly organized interconnected framework of  extracellular 
matrix (ECM) fibers, generating conduits for the movement of  antigens and immune cells within the LN (11, 
The contribution of the kidney-draining lymph node (KLN) to the pathogenesis of ischemia-
reperfusion injury (IRI) of the kidney and its subsequent recovery has not been explored in 
depth. In addition, the mechanism by which repetitive IRI contributes to renal fibrosis remains 
poorly understood. Herein, we have found that IRI of the kidney is associated with expansion 
of high endothelial venules (HEVs) and activation of fibroblastic reticular cells (FRCs) in the 
KLN, as demonstrated by significant expansion in the extracellular matrix. The lymphotoxin 
α signaling pathway mediates activation of FRCs, and chronic treatment with lymphotoxin β 
receptor–immunoglobulin fusion protein (LTβr-Ig) resulted in marked alteration of the KLN as 
well as augmentation of renal fibrosis. Depletion of FRCs reduced T cell activation in the KLN and 
ameliorated renal injury in acute IRI. Repetitive renal IRI was associated with senescence of FRCs, 
fibrosis of the KLN, and renal scarring, which were ameliorated by FRC administration. Therefore, 
our study emphasizes the critical role of FRCs in both the initiation and repair phases of injury 
following IRI of the kidney.
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13). FRCs also maintain the integrity of  HEVs (22). Finally, FRCs contribute to the recovery of  the LN fol-
lowing antigenic stimulation (23). In the setting of  persistent infection, FRCs accumulate permanent damage, 
marked by the production of  excessive amounts of  collagen, leading to fibrosis of  the LN (24–26).
The role of  the kidney-draining LN (KLN) in the pathogenesis of  IRI and its subsequent healing 
phase is relatively unknown, as is the impact of  IRI on KLN structure. The importance of  innate and 
adaptive immune responses to the pathogenesis of  renal IRI has been investigated (27), but the majority 
of  these studies have focused on the recruitment and activation status of  immune cells within the kidney, 
and the KLN has received less attention.
The objective of  this study is to investigate the impact of  IRI on FRCs and key elements of  the ECM 
in the KLN. We demonstrate that the KLN is a critical site of  T cell activation following IRI. The KLN 
undergoes major structural changes in the acute phase following IRI, driven by the activation of  FRCs. 
However, repetitive IRI (IRI(rep)) results in chronic changes in the microarchitecture of  the KLN, including 
the accumulation of  collagen I (Coll 1) and fibronectin (FN) fibers. Following IRI(rep), the administration of  
FRCs restores the microarchitecture of  the KLN and prevents renal fibrosis.
Results
The KLN is the site of  T cell activation and undergoes substantial structural changes driven by the activation of  FRCs fol-
lowing IRI. The KLN was identified by injecting India ink into the abdominal aorta following clamp placement 
and was visualized using live light microscopy (Supplemental Figure 1A; supplemental material available online 
with this article; https://doi.org/10.1172/jci.insight.120546DS1). IRI was induced by a temporary clamp of the 
renal pedicle. To confirm the functional importance of the KLN to the inflammatory response following kidney 
IRI, Rag1–/– mice were injected with CellTrace Violet–labeled CD4+ T cells 2 days following unilateral IRI, and 
their KLNs were harvested. We observed marked increase in T cell proliferation in the KLN draining the isch-
emic kidney (KLN: IRI(D2)), as compared with either the KLN draining the nonischemic contralateral kidney 
(KLN: Ctrl) or the KLN from a naive Rag1–/– mouse (KLN: Naive) (Supplemental Figure 1B).
Next, we performed unilateral IRI using male C57BL/6 mice, and the kidneys and KLNs were har-
vested at 2 days and 30 days after IRI. We observed features of  kidney injury 2 days following IRI in the 
ischemic kidney (Kidney: IRI(D2)), in contrast to the contralateral nonischemic kidney (Kidney: Ctrl) (Sup-
plemental Figure 1C). By 30 days after IRI, the clamped kidney (Kidney: IRI(D30)) had undergone repair, 
with no signs of  tissue fibrosis (Supplemental Figure 1C).
Next, structural changes within the KLNs were assessed following IRI. H&E staining of  the KLN with-
out IRI (KLN: Ctrl) showed typical cortical B cell zones (arrowhead) and paracortical T cell zones with clear 
medullary cords (asterisk). The KLN draining the ischemic kidney harvested 2 days after IRI (KLN: IRI(D2)) 
demonstrated a loss of  compartmentalization of  T and B cell zones, along with substantial cellular expan-
sion, especially in the medulla (Figure 1A). Despite the resolution of  the typical histologic changes associated 
with AKI in the renal parenchyma (Supplemental Figure 1C, Kidney: IRI(D30)), the KLN harvested at 30 days 
after IRI (KLN: IRI(D30)) demonstrated structural disorganization (Figure 1A). Interestingly, both IRI(D2) and 
IRI(D30) KLNs displayed markedly augmented production of  the antigen recognized by ER-TR7 antibody 
(ER-TR7) and FN+ ECM by FRCs, in comparison with the Ctrl KLN (Figure 1A). The IRI(D2) and IRI(D30) 
KLNs displayed an expanded, thickened, and nodular ECM, in contrast to the thin fibrillary pattern observed 
in the Ctrl KLN. The fluorescent signal of  the ECM was increased in both the IRI(D2) and IRI(D30) KLNs, in 
comparison with the Ctrl KLN, as assessed by semiquantitative measurement (Supplemental Figure 1D).
PDPN+ staining was used to study the architecture of  FRCs located away from the lymphatic vascula-
ture of  the KLN (21). Immunofluorescence staining of  FRCs in the IRI(D2) KLN demonstrated elongated 
cellular architecture. However, many FRCs lost their spindle-like shape and had an expanded cytoplasm 
in the IRI(D30) KLN (Figure 1B). Costaining of  FRCs for PDPN and α smooth muscle actin (αSMA) sug-
gested that FRCs underwent a transition to an activated phenotype in the IRI(D2) KLN, an observation that 
was more prominent in the IRI(D30) KLN (Figure 1B). Mean fluorescence intensity of  αSMA in the IRI(D2) 
and IRI(D30) KLNs was significantly increased, as compared with the Ctrl KLN (Supplemental Figure 1D). 
Moreover, marked expansion and elongation of  HEVs were observed in the IRI(D2) KLN, and this pattern 
persisted in the IRI(D30) KLN (Figure 1B). Modest increases in the deposition of  Coll I and the population 
of  F4/80+ macrophages in the IRI(D2) KLN were more significant in the IRI(D30) KLN (Supplemental Figure 
1, D and E). The senescence marker p16INK4A did not increase in either the IRI(D2) or IRI(D30) KLNs, emblem-
atic of  the activated state of  post-IRI FRCs (Supplemental Figure 1E) (28, 29).
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The expression of  CCL19, PDPN, and lymphotoxin β receptor (LTβr) increased significantly in both the 
IRI(D2) and IRI(D30) KLNs, when normalized to the Ctrl KLN (Figure 1C). Concomitantly, the expression of  
profibrotic genes, including αSMA and FN, increased significantly (Figure 1C). Using flow cytometric analy-
sis gated on CD45– cells, we also confirmed a significant increase in the percentage of  FRCs in both the IRI(D2) 
and IRI(D30) KLNs, as compared with the Ctrl KLN (Ctrl KLN vs. IRI(D2) KLN: 32.33% ± 2.5% vs. 45.13% ± 
1.4%, **P < 0.01; and Ctrl KLN vs. IRI(D30) KLN: 25.03% ± 1.7% vs. 44.65% ± 4.8%, **P < 0.01; respectively) 
(Figure 1, D and E). Additionally, the percentage of  lymphatic endothelial cells (LECs) was lower in both 
the IRI(D2) and IRI(D30) KLNs, in comparison with the Ctrl KLN, as assessed by flow cytometry (%LEC: Ctrl 
KLN vs. IRI(D2) KLN, 20.43% ± 1.5% vs. 13.78% ± 1.8%, *P < 0.05; and Ctrl KLN vs. IRI(D30) KLN: 21.29% 
± 1.6% vs. 15.36% ± 1.6%, *P < 0.05; respectively), which is consistent with our findings from immunofluo-
rescence (refer to Supplemental Figure 1E, Lyve1). The proliferation of  FRCs was also significantly greater 
in both the IRI(D2) and IRI(D30) KLNs (%Ki-67+ FRC: Ctrl KLN vs. IRI(D2) KLN, 42.40% ± 5.2% vs. 66.10% ± 
2.9%, *P < 0.05; and Ctrl KLN vs. IRI(D30) KLN: 41.27% ± 0.9% vs. 51.66% ± 3.2%, *P < 0.05; respectively) 
(Figure 1F). In conclusion, FRCs in the KLN were activated 2 days following IRI, and they remained activat-
ed 30 days following IRI, despite evidence of  histological recovery from tubular injury in the kidney.
IRI(rep) of  the kidney causes senescence in KLN-resident FRCs. Since IRI is commonly recurrent, the impact 
of  IRI(rep) on progressive organ damage possesses high clinical relevance. We tested the hypothesis that 
IRI(rep) induces senescence in FRCs and leads to fibrosis in the KLN. To induce IRI(rep), we performed IRI 
3 times in C57BL/6 mice at 2-week intervals. Mice were then sacrificed 2 weeks following the third IRI (8 
weeks after the first IRI). Histological analysis of  the kidney following IRI(rep) demonstrated tubular injury 
and interstitial hypercellularity by H&E, as well as interstitial fibrosis by Masson’s trichrome staining (Sup-
plemental Figure 2A). Analysis of  gene expression in the kidney revealed an increase in proinflammatory 
markers, such as interferon γ (IFN-γ), tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β), and IL-6, 
and fibrosis markers, such as FN, Coll I, and αSMA (Supplemental Figure 2B). The IRI(rep) KLN showed 
marked morphologic changes, including loss of  compartmentalization, loss of  organization of  B and T 
cell zones, and interstitial hypocellularity (Figure 2A). In addition, deposition of  ER-TR7 and FN fibers 
increased, and their pattern of  staining was patchy and lobular in the IRI(rep) KLN (Figure 2A, arrowheads), 
unlike the typical linear staining observed in Ctrl KLN (refer to Figure 1A, KLN: Ctrl). This finding cor-
related with an increase in FN gene expression in the IRI(rep) KLN (Supplemental Figure 2C).
Chronic injury leads to fibrosis, due to the formation of  a fibrous scar resulting from activation of  
Coll I–producing myofibroblasts (30–33). We observed a marked increase in the staining of  Coll I in the 
IRI(rep) KLN (Figure 2A, inset; dashed lines mark B cell zone). This finding was confirmed by gene expres-
sion analysis (*P < 0.05, Supplemental Figure 2C). Coll I can function as a macrophage chemoattractant 
(34). Indeed, we observed an increase in the infiltration of  F4/80+ macrophages, in association with aug-
mented deposition of  Coll I fibers following IRI(rep) (Figure 2A). Macrophage-specific gene expression of  
F4/80 was also increased (Supplemental Figure 2C). PDPN-expressing FRCs appeared lobular with an 
edematous cytoplasm in the IRI(rep) KLN (Figure 2A), as compared with the Ctrl KLN (refer to Figure 1A, 
KLN: Ctrl). Moreover, flow cytometric analysis of  the IRI(rep) KLN revealed a significant decrease in the 
proportion of  FRCs in the KLN, as expressed by the percentage of  CD45– cells (Ctrl KLN vs. IRI(rep) KLN: 
35.80% ± 3.4% vs. 11.34% ± 1.8%, **P < 0.01), and a marked decrease in the frequency of  proliferating 
(Ki67+) FRCs (Ctrl KLN vs. IRI(rep) KLN: 45.10% ± 5.5% vs. 23.35% ± 1.8%, **P < 0.01) (Figure 2B).
Figure 1. Activation of fibroblastic reticular cells (FRCs) results in major structural changes in kidney-draining lymph node (KLN) following ischemia-reper-
fusion injury (IRI) of the kidney. (A) KLN draining ischemic kidney shows loss of T and B cell zone differentiation, as compared with the KLN draining 
nonischemic kidney (KLN: Ctrl) at 2 days (KLN: IRI(D2)) and 30 days (KLN: IRI(D30)) following IRI. Arrows point to cortical B cell zone, dashed line divides cortical 
from subcortical T cell zone (arrowheads), while dotted line divides subcortical zone from the medulla containing medullary chordae (inset: asterisk). At 
both time points, fluorescence reveals increased interstitial extracellular matrix (ECM) in KLN tissue: ER-TR7 and fibronectin (insets show thickened and 
nodular pattern). Scale bars: 500 μm and 200 μm (inset) for H&E; 200 μm and 100 μm (inset) for ER-TR7 and fibronectin. (B) FRC signal (podoplanin, PDPN) 
is increased at 2 days (KLN: IRI(D2)) and 30 days (KLN: IRI(D30)) following IRI (inset shows enlarged cytoplasm). Costaining of PDPN and α smooth muscle actin 
(αSMA) suggests FRC transition in KLN following IRI of the kidney. High endothelial venules (HEVs) stained with MECA79, which labels peripheral node 
addressin on HEVs, show expansion and elongation 2 days and 30 days following IRI. Scale bars: 200 μm and 100 μm (inset) for PDPN; 100 μm for αSMA+PD-
PN and MECA79. (C) Following IRI, KLN tissue expresses increased activated FRC gene transcripts, as assessed by qPCR (n = 4/group, mean ± SEM). (D) Flow 
cytometry of KLNs shows increased CD45–PDPN+CD31– FRC percentage at 2 days following IRI (gated on CD45– cells, representative flow plots) (n = 6/group, 
mean ± SEM). (E) Flow cytometry of KLNs shows increased CD45–PDPN+CD31–FRC percentage at 30 days following IRI (gated on CD45– cells, representative 
flow plots) (n = 5/group, mean ± SEM). (F) Flow cytometry of KLNs showed increased percentage of proliferating (Ki-67+) FRCs 2 days and 30 days following IRI 
in comparison with KLN of nonischemic kidney (n = 3–4/group, mean ± SEM). *P < 0.05; **P < 0.01 by Student’s t test.
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Next, we sought to assess the cause of  the decrease in frequency and proliferation of  FRCs. Increased 
p16INK4A (Figure 2A, inset) staining was seen in areas where αSMA expression was more intense in the IRI(rep) 
KLN (Figure 2A, dashed line; B cell zone areas). In contrast, senescence of  FRCs was not observed at either 
day 2 or 30 after a single episode of  IRI (refer to Supplemental Figure 1E, KLN: IRI(D2) and KLN: IRI(D30)).
Furthermore, gene expression of  αSMA, Coll I, FN, and F4/80 was increased in the IRI(rep) KLN, as 
compared with the Ctrl KLN (Supplemental Figure 2C). The vessel walls of  HEVs were markedly thickened 
in the IRI(rep) KLN (Figure 2A). In addition, Lyve1+ staining demonstrated a regression of  LEC networks 
(Figure 2A), and flow cytometric analysis indicated that the proportion of  LECs was decreased in the IRI(rep) 
KLN in comparison with the Ctrl KLN, as represented by the percentage of  CD45– cells (Ctrl KLN vs. IRI(rep) 
KLN: 11.80% ± 2.1% vs. 3.93% ± 1.1%, *P < 0.05) (Figure 2B).
We then characterized the microstructure of the KLN using electron microscopy. A clear FRC-HEV unit, 
containing cuboidal HEV cells (Figure 2C, white asterisk) surrounded by spindle-like FRCs (Figure 2C, white 
arrowhead), was observed in the Ctrl KLN. Lymphocytes were observed trafficking between HEV cells into the 
interstitium of the KLN (Figure 2C, black arrows). However, the IRI(rep) KLN demonstrated flattened perivas-
cular FRCs and HEV cells, as well as detached HEVs obstructed by proteinaceous material (Figure 2C, KLN: 
IRI(rep)). The interstitial substructure revealed collagen fibrils (Figure 2C, KLN: IRI(rep), black asterisk, and inset) 
and numerous vacuoles (black arrowheads) in HEV cells, a finding suggestive of vascular injury (35).
To further assess senescence in the FRCs of  KLNs following IRI(rep), we isolated these cells, cultured 
them in vitro, and stained them for β-galactosidase, a commonly used in vitro senescence marker (Figure 
2D). The IRI(rep) KLN contained a significantly higher ratio of  β-galactosidase+ FRCs to total number of  
cells than the Ctrl KLN (Ctrl KLN vs. IRI(rep) KLN: 15.33% ± 2.8% vs. 48.67% ± 3.2%, **P < 0.01) (Figure 
2D) (28, 29). Senescent cells also form lysosome-like vacuoles (36), and these were observed in abundance 
in the cytoplasm of  cultured senescent FRCs (Figure 2D, arrowhead).
FRCs are activated via the lymphotoxin α signaling pathway. Next, we tested the hypothesis that T cells can 
activate FRCs through the action of  membrane-bound lymphotoxin α (LTα), as FRCs express LTβr (37–39), 
the receptor to which LTα binds. We performed the adoptive transfer of  T cells (2.0 × 107 cells/mouse) from 
either C57BL/6 (WT) or LTα-KO mice (LTα–/–) into Rag1–/– mice 1 day prior to IRI. Two days after IRI, flow 
cytometric analysis indicated that the proportions of  FRCs and proliferating (Ki-67+) FRCs were significantly 
higher in the KLN of the Rag1–/– mice that received an injection of  WT T cells, in comparison with LTα–/– T 
cells, as represented by percentages of  CD45– cells (%FRC: WT vs. LTα–/– KLN, 17.00% ± 1.7% vs. 7.22% 
± 0.7%, **P < 0.01; %Ki67+ FRC: WT vs. LTα–/– KLN, 32.95% ± 3.4% vs. 15.66% ± 1.4%, **P < 0.01; 
respectively) (Figure 3A). Interestingly, the kidneys of  Rag1–/– mice that received LTα–/– T cells appeared to 
be relatively protected from IRI. H&E staining of  these kidneys revealed prominently fewer tubular casts and 
reduced thinning of  the tubular epithelium (Figure 3B). In concordance with this, blood urea nitrogen (BUN) 
was significantly lower in Rag1–/– mice adoptively transferred with LTα–/– T cells, as compared with the con-
trol group (WT vs. LTα–/–: 95.57 ± 6.242 vs. 40.75 ± 15.16 mg/dl, *P < 0.05) (Figure 3C).
Depletion of  FRCs ameliorates AKI following IRI. FRCs recruit T cells to the LN via secretion of  CCL19 
(11, 23, 40), where subsequently they become activated during IRI. Thus, we assessed whether the depletion 
Figure 2. Repetitive renal IRI induces senescence in KLN-resident FRCs. KLNs were harvested 2 weeks after the induction of the third IRI (KLN: IRI(rep)). (A) 
Microscopy shows marked hypocellularity and loss of differentiation between cortical and subcortical zones. Both ER-TR7 and fibronectin staining insets 
illustrate areas of lobulated and thickened ECM. Arrowheads in ER-TR7 and fibronectin staining demonstrate areas of excessive ECM deposits with intersti-
tial swelling. Collagen I matrix is increased, especially in subcortical areas, and ECM is expanded in the subcortical T cell zone, proximal to the B cell zone in 
costaining of KLN with Coll I and F4/80 (see dashed lines in inset). FRC staining demonstrates enlarged cytoplasms (inset in PDPN). Many KLN interstitial 
cells are stained with αSMA. Several of these cells are senescent (p16INK4A+), especially in the subcortex (next to the dashed line); inset: close-up of senescent 
cells. HEV structure is markedly thickened (close-up image in inset). Lyve1 stain reveals regression of the lymphatic endothelial network. Scale bars: 500 μm 
and 200 μm (inset) for H&E; 200 μm and 100 μm (inset) for ER-TR7, PDPN, and αSMA+p16INK4A; 500 μm and 100 μm (inset) for fibronectin and CollI+F4/80; 
100 μm and 50 μm (inset) for MECA79; 200 μm for Lyve1. (B) Flow cytometric analysis of CD45– cells from KLNs following repetitive IRI (KLN: IRI(rep)) or without 
repetitive IRI (KLN: Ctrl) shows significantly decreased percentages of CD45–PDPN+CD31– FRCs and proliferating (Ki67+) FRCs, along with representative flow 
cytometry plots (n = 4–6/group, mean ± SEM). (C) Electron microscopy of naive KLN shows HEV endothelium (white asterisks) and supporting perivascular 
FRCs (white arrowheads). Arrows indicate lymphocytes in active diapedesis into the interstitium of the KLN (KLN: Ctrl). KLN following repetitive IRI (KLN: 
IRI(rep)) shows obliteration of the HEV lumen with detachment of HEV cells (white asterisks) from the vessel’s basement membrane and intrusion into the 
lumen. White arrowheads indicate perivascular FRCs. Some HEV cells show denser and smaller nuclei, along with shrunken cytoplasm, and HEV has intralumi-
nal ECM deposits (black arrowheads). (D) FRCs from KLNs of mice with or without repetitive IRI were cultured in vitro and stained with β-galactosidase (senes-
cence marker). Micrograph of FRCs from KLN following repetitive IRI showed senescent cells with lysosome-like vacuoles (white arrowhead) at a significantly 
higher percentage than FRCs from the KLNs of naive mice (n = 6/group, mean ± SEM). **P < 0.01 by Student’s t test.
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of FRCs reduces kidney injury following IRI. To deplete FRCs, we used transgenic CCL19Cre × iDTR mice, 
in which FRCs are depleted upon administration of  diphtheria toxin (DT) (15, 41). To assess the potential 
impact of  DT-induced depletion of  FRCs in the kidney, we first measured the BUN of naive CCL19Cre × 
iDTR mice with or without DT administration. No significant difference in BUN between the groups was 
observed (data not shown). Furthermore, no change in the morphology of  the glomeruli or tubules was not-
ed following DT administration (Supplemental Figure 3, A and B). The expression of  CCL19 in cultured 
podocytes was almost undetectable, as compared with the KLN (Supplemental Figure 3C). Then, DT was 
administrated to CCL19Cre × iDTR mice prior to bilateral IRI, and the mice were sacrificed 2 days following 
IRI. We observed a marked decrease in the signal of  PDPN+ FRCs in the KLN of CCL19Cre × iDTR mice, as 
compared with the KLN of WT mice (Figure 3D). FRC depletion prevented the expansion of  the HEV net-
work following IRI (Figure 3D). Quantification by flow cytometry showed a significant decline in the popula-
tions of  both FRCs and HEV cells in the CCL19Cre × iDTR KLN, in comparison with the WT KLN (Figure 
3E). The kidneys of  CCL19Cre × iDTR mice showed less severe acute tubular necrosis (ATN), as manifested 
by decreased tubular casts and reduced tubular thinning (Figure 3F). Depletion of  FRCs also led to a marked 
decrease in macrophage infiltration into the kidneys following IRI (Figure 3F, lower panel). Moreover, the 
cortices in the kidneys of  FRC-depleted mice were thickened significantly in comparison with the WT kid-
neys 2 days following IRI, as assessed by a cortical thickness score (WT vs. CCL19Cre × iDTR: 1.6 ± 0.48 vs. 
2.75 ± 0.21, *P < 0.05) (Figure 3G, left). Finally, the BUN of CCL19Cre × iDTR mice was commensurately 
lower than the WT mice (68.03 ± 4.1 vs. 29.0 ± 4.5 mg/dl, **P < 0.01) (Figure 3G, right).
Next, we investigated whether FRC depletion altered the proinflammatory T cell profile in the KLN 
following IRI. At day 2 following IRI, the absolute numbers of  proinflammatory CD4+IFN-γ+ T cells (WT 
vs. CCL19Cre × iDTR: 3,112.4 ± 1,110 vs. 892.1 ± 191.8, *P < 0.05) and activated CD4+CD44hi T cells (WT 
vs. CCL19Cre × iDTR: 7,602.1 ± 1,405 vs. 1,895.2 ± 648.2, *P < 0.05) were significantly lower in the KLN of  
the CCL19Cre × iDTR mice in comparison with the WT mice (Figure 3H). These studies suggest a vital role 
of  KLN-resident FRCs in the pathogenesis of  the acute inflammatory response in the kidney following IRI.
LTβr-Ig treatment enhances renal fibrosis following IRI. FRCs can stimulate the immune response through 
the recruitment of  T cells, but they can also inhibit the immune response, through their ability to produce 
immunoregulatory molecules (23). Proper healing of  organs following an initial ischemic insult relies on 
the activation of  regulatory immune responses to counteract the proinflammatory processes (9, 42). We 
tested the hypothesis that chronic suppression of  the LTα signaling pathway interferes with the healing 
phase following renal IRI. Prolonged treatment with DT over several weeks is associated with significant 
toxicity. Therefore, we treated mice that underwent renal IRI with LTβr-immunoglobulin fusion protein 
(LTβr-Ig). LTβr plays an important role in the function and maturation of  FRCs (43). LTβr-Ig functions 
as a decoy protein, interfering with the interaction between LTα and LTβr (44). Starting 4 days prior to 
bilateral renal IRI, LTβr-Ig was injected intraperitoneally (i.p.) every 2 days, including the day of  surgery. 
After surgery, it was given 3 times weekly, until the mice were sacrificed 30 days following IRI. Exper-
imental control mice were treated with control IgG. Upon histological assessment at 30 days after IRI, 
we observed that the kidneys from the mice treated with LTβr-Ig did not display signs of  recovery from 
IRI, in comparison with the control group (Figure 4A). LTβr-Ig–treated mice had increased tubuloint-
erstitial fibrosis (Figure 4A), with a marked increase in myofibroblast transition, as evidenced by αSMA 
expression in the interstitium (Figure 4A). Kidney tissue showed excessive layering of  FN and increased 
infiltration with F4/80+ macrophages, following treatment with LTβr-Ig (Figure 4A). Similarly, KLNs 
of  mice injected with LTβr-Ig displayed signs of  fibrosis, including a marked increase in FN expression 
(Figure 4B). In keeping with the histological appearance, the BUN was significantly higher on day 30 in 
the mice that received LTβr-Ig, as opposed to the control IgG (IgG vs. LTβr-Ig: 14.53 ± 3.4 vs. 26.63 ± 
5.2 mg/dl, *P < 0.05) (Figure 4C). These experiments suggest that the inhibition of  FRCs in the KLN 
with LTβr-Ig hinders renal repair following IRI and leads to fibrosis.
FRC infusion alleviates renal fibrosis following recurrent IRI. Next, we hypothesized that the infusion of  
exogenous FRCs could restore the anatomy of  the KLN and prevent renal scarring following IRI(rep).
FRCs were isolated from the LN and expanded in vitro as previously described (45). To confirm the 
homing of  FRCs to the KLN following IRI, we labeled FRCs with IR800-loaded PLGA nanoparticles (FRC-
IR800-NPs). Following injection, FRC-IR800-NPs localized preferentially to the KLN draining the ischemic 
kidney (Figure 5A, white arrow), as compared with the KLN draining the nonischemic kidney (Figure 5A, 
blue arrow); no signal was detected in the nondraining popliteal LN (Figure 5A, white arrowheads).
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Next, we subjected mice to bilateral renal IRI(rep) as above — 3 occasions of  IRI, separated by inter-
vals of  2 weeks — and injected them with FRCs (passage 3 to 4) intravenously, immediately prior to each 
renal insult. Flow cytometric analysis of  KLNs confirmed homing of  FRCs to the KLNs after IRI (vehicle 
vs. FRC: 3,640 ± 933.2 vs. 8,985 ± 1,432, **P < 0.01) (Figure 5B). Two weeks following the final insult, 
the mice that received exogenous FRCs displayed decreased kidney injury on H&E staining, as mani-
fested by reductions in tubular dilation (Figure 5C, arrowheads), interstitial expansion, cellularity (Figure 
5C, arrows), and tissue fibrosis by Masson’s stain (Figure 5C), as compared with the vehicle-treated mice. 
Immunofluorescence of  kidneys from FRC-treated mice also displayed lower FN density and diminished 
macrophage infiltration, as compared with the control group (Figure 5D). Semiquantitative analysis of  the 
fluorescence signals confirmed these findings in FRC-treated mice (vehicle vs. FRC: FN, 35.68 ± 4.4 vs. 
19.02 ± 2.8, **P < 0.01; macrophage, 24.92 ± 4.3 vs. 8.63 ± 3.1, *P < 0.05) (Figure 5E). Flow cytometric 
analysis of  infiltrating cells in the kidney revealed a marked reduction in the macrophage population in the 
kidneys of  mice treated with FRCs (vehicle vs. FRC: 14.96 × 104 ± 1.9 × 104 vs. 8.04 × 104 ± 1.5 × 104, **P 
< 0.01) (Figure 5F). Interestingly, histological assessment of  the KLNs from the FRC-treated mice showed 
improved architecture with well-demarcated B cell, T cell, and medullary zoning, as compared with the 
vehicle-treated mice (Figure 5G).
Discussion
FRCs play an important role in supporting the structure of  the LN, and their functions include the recruit-
ment of  immune cells, production of  ECM, and maintenance of  HEV integrity (23, 46–48). Furthermore, 
FRCs participate in LN recovery and remodeling following acute infections (23). These functions are criti-
cally important to the generation of  an antigen-specific immune response (11, 12, 21, 23). Although FRCs 
are vital in the control of  antiviral immunity (23, 41, 49), their role in the pathogenesis of  immune responses 
following ischemic organ injury is unknown. We have found that the KLN is the site of  T cell activation 
following IRI of  the kidney, as we observed a considerable expansion of  immune cells. Also following IRI, 
FRCs in the KLN proliferated and increased the production of  ECM. Additionally, we noted an expansion 
of  the HEV cell population. These histological changes in the KLN persisted despite full renal recovery fol-
lowing a solitary episode of  IRI. This lack of  full recovery could be due to ongoing inflammatory processes.
Repetitive ischemic kidney injury is known to contribute to the progression of  chronic kidney disease 
(50). Moreover, persistent stimulation of  FRCs has been demonstrated to induce phenotypic changes, where-
by FRCs produce large amounts of  collagen, leading to fibrosis in the LN (49, 51). Indeed, following IRI(rep), 
we found that the KLN demonstrated excessive deposition of  ECM fibers containing FN and Coll I, as well 
as decreased density of  FRCs. While the pattern of  ER-TR7 and FN in the nonischemic KLN is continu-
ous and linear, a lobular pattern of  FN deposition is observed in the KLN following IRI. We also noted a 
significant increase in macrophage frequency, in keeping with prior observations by others (52, 53). FRCs 
also maintain the integrity of  HEVs (54), and we observed marked obliteration of  HEVs following IRI, with 
proteinaceous and fibrous material laid outside these vessels. The HEV is central to determining the fate of  
immune responses through its important role in facilitating the entrance of  immune cells into the LN.
Collagen and other ECM fibers, such as FN, accumulate in fibrotic tissues (55). The accumulation 
of  collagen and FN in the post-IRI(rep) KLN shares pathological characteristics with fibrosis within other 
organs (56). Excessive deposition of  collagen results in defects in the mechanical properties of  organs, 
Figure 3. FRCs play a crucial role in the augmentation of immune activation following IRI. (A) Flow cytometric analysis shows a higher percentage of 
CD45–PDPN+CD31– FRCs and proliferating (Ki67+) FRCs in KLNs harvested 2 days following IRI from Rag1–/– mice injected with WT T cells than KLNs from those 
injected with LTα–/– T cells, along with representative flow cytometry plots (gated on CD45– cells) (n = 3–4/group, mean ± SEM). (B) H&E staining (scale bar: 75 
μm) of kidney tissue from Rag1–/– mice following IRI demonstrates renal protection upon adoptive T cell transfer from LTα–/– mice, along with (C) lower BUN, 
as compared with Rag1–/– mice that received T cells from WT mice (n = 3/group, mean ± SEM). (D) Immunofluorescence of KLN shows marked decrease in 
PDPN+ FRCs in DT-treated CCL19Cre × iDTR mice as compared with untreated WT mice. Paucity in HEV abundance and abrogation of architectural elongation is 
also shown. Scale bars: 200 μm for PDPN, 100 μm for MECA79. (E) Absolute cell counts of FRCs and HEVs are significantly lower in the KLNs of CCL19Cre × iDTR 
mice, in comparison with the KLNs from WT mice, as determined by flow cytometric analysis (n = 3/group, mean ± SEM). (F) FRC depletion leads to amelio-
ration in kidney damage after IRI. H&E staining shows less tubular injury in CCL19Cre × iDTR mice, as compared with WT mice. F4/80 staining indicates tissue 
inflammation is markedly decreased in CCL19Cre × iDTR mice after IRI. LTL identifies proximal tubules. Scale bars: 75 μm. (G) Left panel: Mean cortical thickness 
of kidneys in FRC-depleted mice was higher than in WT mice following IRI (n = 6/group, mean ± SEM). Right panel: CCL19Cre × iDTR mice are protected from 
IRI, as indicated by lower BUN (mg/dl) (n = 6/group, mean ± SEM). (H) Left panel: Absolute count of CD4+IFN-γ+ T cells in KLN is significantly lower in CCL19Cre 
× iDTR mice in comparison with WT mice following IRI. Right panel: Absolute count of CD4+CD44hi T cells in KLN is significantly lower in CCL19Cre × iDTR mice in 
comparison with WT mice (n = 3–4/group, mean ± SEM). *P < 0.05; **P < 0.01 by Student’s t test.
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such as increased stiffness (57). Given the importance of  contractility of  FRCs to the expansion of  the 
LN in a mounting immune response, it would be of  considerable interest to assess the effect of  altered 
stiffness of  the KLN following IRI(rep) on renal outcomes (58).
FRCs share many features with mesenchymal stem cells (MSCs) (i.e, CD73 and CD90 expression). 
Though cellular senescence was originally described in fibroblasts, MSCs under stress have similarly been 
demonstrated to undergo senescence (59, 60). Senescent cells experience growth arrest, but they maintain 
Figure 4. LTβ receptor–immunoglobulin (LTβr-Ig) treatment 
enhances renal fibrosis following IRI. (A) Ischemic kidney from 
mouse treated with LTβr-Ig fails to recover histologically (H&E) 
30 days following IRI and shows tissue fibrosis (Masson T), in 
comparison with the kidney from mouse treated with control IgG. 
Thirty days following IRI, the ischemic kidney from mouse treat-
ed with LTβr-Ig shows increased staining of αSMA, fibronectin, 
and F4/80, as compared with the kidney from mouse treated 
with control IgG. Scale bars: 75 μm. (B) Thirty days following IRI, 
KLN from mouse treated with LTβr-Ig shows marked increase in 
fibronectin staining, as compared with KLN from mouse treated 
with control IgG. Scale bar: 200 μm. (C) Thirty days following IRI, 
BUN is significantly higher in mouse receiving LTβr-Ig, as com-
pared with mouse treated with control IgG (n = 5–6/group, mean 
± SEM). *P < 0.05 by Student’s t test.
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metabolic activity and can produce a variety of  molecules, including cytokines. This cellular state is referred 
to as the senescence-associated secretory phenotype and could potentially stimulate a proinflammatory 
milieu within the KLN (61). FRCs isolated from the KLNs of  mice experiencing repetitive ischemia displayed 
a significant decline in proliferation and experienced increasing growth arrest in cultures. They also appeared 
enlarged and crowded with vacuoles, and they exhibited senescence-associated β-galactosidase activity (62).
FRCs express LTβr, which allows them to interact with LTα. This interaction has been found to be 
crucial to the development of  LNs (43). It should be noted that LTα on the surface of  immune cells exists 
as a heterotrimer of  LT α1/β2. LTα is also present in a secreted form as homotrimeric LTα3, which acts on 
TNFR1/2, not LTβr (63). Here, we tested the hypothesis that the activation of  FRCs occurs via signaling 
through the LTα/LTβr pathway. Adoptive transfer of  T cells from LTα–/– mice into Rag1–/– mice protected 
against kidney injury following IRI, as compared with Rag1–/– mice that received T cells from WT mice, 
indicating the crucial role of  LTα in the activation of  FRCs by T cells following IRI.
Next, we tested the hypothesis that the depletion of  FRCs reduces AKI following IRI through the 
utilization of  a transgenic CCL19Cre × iDTR mouse model, as previously described (15, 64). CCL19-Cre × 
Rosa26-EYFP reporter mice were generated by crossing the CCL19-Cre line with Rosa26-enhanced yellow 
fluorescent protein (EYFP) mice, which allowed for the identification of  FRCs as well as their depletion, 
through the addition of  the DTR gene (15). We found that animals depleted of  FRCs showed less severe 
renal injury, along with fewer kidney-infiltrating inflammatory cells, in the acute phase following IRI. The 
KLN of  FRC-depleted mice also contained significantly fewer activated proinflammatory T cells. This 
difference could be due to the importance of  CCL19-bearing FRCs to the recruitment of  immune cells via 
HEVs to the KLN in the setting of  IRI (11, 12, 23).
CCL19 has been reported to be expressed by cultured podocytes and kidneys suffering from chronic 
glomerular diseases (65, 66). Given the acuity of  our model, it is unlikely the effect we noted on renal 
function following DT therapy resulted from depletion of  CCL19-expressing cells of  normal kidneys. Fur-
thermore, the glomeruli and tubules of  the kidney did not demonstrate any significant histological changes 
following DT therapy in CCL19Cre × iDTR mice.
In order to tightly control the microenvironment of  LN, FRCs carry the potential to have both proinflam-
matory and regulatory functions (23, 67). The initiation of  immunoregulatory processes mediated by FRCs 
within the KLN likely promotes organ healing by suppressing inflammatory responses (68–71). Because 
chronic depletion of  FRCs with DT is challenging due to the high toxicity rate of  long-term use, we sought to 
block the LTβr pathway to assess whether this alteration interferes with the healing phase of  renal IRI.
LTβr-Ig was tested for its therapeutic efficacy in an immune complex glomerulonephritis model (72). 
LTβr-Ig was efficacious in reducing proteinuria, when it was administered from 3 to 7 weeks following ini-
tiation of  this disease model. However, earlier LTβr-Ig treatment resulted in high mortality. In addition, 
beginning the treatment at 5 weeks resulted in no significant effect on renal outcomes. In keeping with this 
observation, Bromberg’s group has shown that LTβr-Ig treatment significantly altered stromal subsets of  LNs, 
eroding transplant tolerance and resulting in organ fibrosis (73). Similarly, in our model, LTβr-Ig treatment 
augmented renal fibrosis following IRI. These data could suggest dynamism in the role that signaling through 
the LTβr pathway plays at different stages of  immune-mediated diseases (43).
It is important to note while interpreting these findings that LTβr and its ligands can bind to sev-
eral other types of  receptors and ligands, which adds to the complexity of  the system. For instance, 
LIGHT is a tumor necrosis factor–related cytokine that also binds to LTβr. Interestingly, LTβr-Ig binds 
to both heterotrimeric membrane-bound LTα1β2 and LIGHT (74). Future studies are needed to fur-
ther delineate the relative role of  LIGHT (and its receptors HVEM and decoy receptor 3) in the patho-
Figure 5. Injection of FRCs ameliorates chronic renal injury following repetitive IRI. (A) IR800-NP–labeled FRCs preferentially traffic to KLN draining 
injured kidney (arrowhead: popliteal LN; white arrow: KLN draining ischemic kidney; blue arrow: KLN draining non-ischemic kidney). (B) Flow cytometric 
analysis demonstrates that injection of FRCs at time of recurrent IRI leads to increased FRC population in KLN in comparison with injection of vehicle (n 
= 3/group, mean ± SEM). (C) Light microscopy shows amelioration of kidney injury in mice injected with FRCs at the time of recurrent IRI, as compared 
with mice injected with vehicle (arrowheads: cast-filled and dilated tubules; arrow: interstitial expansion and hypocellularity). Masson’s trichrome staining 
shows decreased fibrosis in FRC-treated mice. Scale bars: 75 μm. (D) Substantial declines in fibronectin density and F4/80+ macrophage infiltration of 
kidney is observed following FRC injection at the time of recurrent IRI. Scale bars: 75 μm. (E) Semiquantitative analysis of the corresponding fluorescent 
signals in kidney tissue shows significantly lower signals in the FRC-treated group (n = 5–6/group, mean ± SEM). (F) Absolute count of kidney-infiltrating 
macrophages following IRI, as measured by flow cytometry, confirms a significant drop in macrophage recruitment with FRC treatment (n = 5/group, mean 
± SEM). (G) FRC injection prevents architectural changes in KLN following IRI. Scale bars: 500 μm (left) and 200 mm (right). *P < 0.05 by Student’s t test.
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genesis of  fibrosis in the LN following IRI(rep). Future studies are also needed to uncover the identities 
of  the signaling molecules downstream of  LTβr in FRCs, differentiating between members of  the 
NF-κB pathway and the noncanonical NF-κB pathway (75, 76).
Moreover, some of  the effects we observed using LTβr-Ig could be due to its effects on HEVs (75), and 
the potential impact of  LTβr-Ig on the formation of  tertiary lymphoid tissue (TLT) in the inflamed organ 
should be investigated. Mii et al. have shown that old mice can develop TLT in the kidneys following IRI, 
but interestingly young mice lack this capacity (77).
Finally, exogenous FRCs were found to traffic to the KLN during IRI. Administration of  FRCs led to 
the restoration of  the microarchitecture within the KLN and significantly ameliorated the development of  
renal fibrosis following repetitive IRI. Similarly, others have shown that administration of  FRCs improved 
inflammatory responses and survival significantly in a murine model of  sepsis (45).
In summary, IRI of  the kidney results in activation of  the FRCs within the KLN. Depletion or inhi-
bition of  FRCs in the acute phase following renal IRI results in the suppression of  renal injury. IRI(rep) is 
associated with the disruption of  the organized structural framework within the KLN and impaired renal 
recovery. Chronic blockade of  the LTα/LTβr pathway also results in fibrosis of  the KLN and kidney. Final-
ly, our findings highlight the considerable potential of  FRCs as a cellular therapy to control inflammation 
and promote renal repair following IRI, one of  the most common causes of  progressive renal fibrosis.
Methods
Reagents and antibodies. Tissue culture reagents (PBS, DMEM, Basal Media Eagle, FBS, and penicillin/strep-
tomycin) were purchased from Gibco (a division of  ThermoFisher Scientific). Paraformaldehyde (20%) was 
purchased from Electron Microscopy Sciences. DT was purchased from List Biological Laboratories, ket-
amine from Zoetis, and xylazine from Santa Cruz Biotechnology. Triton X-100 was from Acros Organics, 
phorbol 12-mystirate 13-acetate (PMA) from Sigma-Aldrich, GolgiStop protein transport inhibitor from BD 
Biosciences, collagenase P from Roche Diagnostics, dispase II from Sigma-Aldrich, DNAse I from Roche 
Diagnostics, and Dulbecco’s PBS from Mediatech. Prolong-Gold mounting media was from Invitrogen.
Antibodies utilized in these studies include Cy3-conjugated anti-αSMA (Sigma-Aldrich, catalog 
C6198; 1:500), rabbit anti-FN (Abcam, catalog ab23750; 1:500), rat anti-ERTR7 (Santa Cruz Biotech-
nology, catalog sc73355), rat anti-F4/80 (Abcam, catalog ab6640; 1:500), FITC-conjugated anti–Lotus 
tetragonolobus lectin (anti-LTL) (Vector Labs, catalog FL-1321; 1:1,000), rabbit anti-Ki67 (Vector Labs, cat-
alog VP-RM04; 1:500), APC-conjugated anti-PDPN (BioLegend, catalog 127409), anti-PDPN (R&D Sys-
tems, catalog AF3244; 1:200), anti-Lrp2/Megalin (Abcam, catalog ab76969; 1:100), FITC-conjugated anti-
HEV (eBioscience, catalog 53-6036-82), FITC-conjugated anti-Lyve1 (R&D Systems, catalog FAB2125G), 
anti-p16INK4A (Abcam, catalog ab189034), anti–Coll I (Abcam, catalog ab34710), anti-CD4-Brilliant Violet 
510 (eBioscience, catalog 100559) or anti-CD4-PE (eBioscience, catalog 100408), anti-CD44-PE (BioLeg-
end, catalog 103023), and anti-IFN-γ-APC (BioLegend, catalog 505810). Secondary antibodies were either 
FITC- or Cy3-conjugated (Jackson ImmunoResearch).
Mice. C57BL/6, B6.129S7-Rag1tm1Mom/J (Rag1–/–), B6.129S2-Ltatm1Dch/J (LTα–/–), and C57BL/6-Gt 
(ROSA)26Sortm1 (HBEGF)Awai/J (C57BL/6-iDTR) were purchased from Jackson Laboratories. CCL19Cre [Tg 
(Ccl19-cre)489Biat] mice were a gift from Shannon Turley at Genentech, South San Francisco, California, 
USA. C57BL/6-iDTR mice were backcrossed with CCL19Cre mice and CCL19Cre × iDTR mice were gen-
erated. Offspring were genotyped by PCR per the protocol from Jackson Laboratories.
Animal surgery. For the IRI experiments, mice were anesthetized with a mix of  ketamine (80–100 mg/
kg) and xylazine (5–10 mg/kg) by i.p. injection. Kidneys were exposed through flank incisions. Ischemia 
was induced by clamping of  renal pedicles with nontraumatic microaneurysm clamps (Roboz Surgical 
Instruments Co.) for either 20 minutes in bilateral IRI or 30 minutes in unilateral IRI. Body temperature 
was maintained at 36.5°C–37.3°C. After the clamps were removed, reperfusion of  the kidneys was con-
firmed visually. Blood was taken from the axillary artery at the time of  sacrifice. BUN levels were measured 
using the Infinity Urea assay (ThermoFisher Scientific), according to the manufacturer’s instructions.
FRC depletion using DT. CCL19Cre × iDTR mice were injected with 100 ng of  DT i.p. on day –2, day –1, 
and day 0 prior to IRI.
LTβr-Ig treatment. LTβr-Ig and isotype control ragweed-specific mouse IgG2a antibody were gifts from 
Genentech. C57BL/6 mice were treated with either control IgG (10 mg/kg) or LTβr-Ig (10 mg/kg) every 2 
days, starting 4 days prior to IRI. The treatment was continued 3 times per week until the mice were sacrificed.
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Histological studies. Kidneys and KLNs were fixed with 4% paraformaldehyde for 2 hours on ice, incu-
bated in 30% (vol/vol) sucrose at 4°C overnight, and embedded in optimum cutting temperature com-
pound (Sakura FineTek). For paraffin sections, tissues were fixed with 10% (vol/vol) formalin, embedded 
in paraffin, and 5-μm sections were cut.
For immunostaining of  kidney and KLN tissue, frozen sections were cut at 7-μm thickness and 
mounted on Superfrost slides (ThermoFisher Scientific). Sections were washed with PBS and perme-
abilized with 0.1% Triton X-100 in PBS. Samples were blocked with 5% (vol/vol) normal goat serum 
in PBS and incubated with primary antibodies. They were then washed and incubated with secondary 
conjugated antibodies. DAPI mixed in Prolong-Gold mounting media was used as a nuclear counter-
stain. Images were obtained by confocal (Nikon C1 Eclipse) or standard (Nikon Eclipse 90i) micros-
copy. All images were automatically processed using ImageJ (NIH) and split into RGB channels. Auto 
threshold was used to convert intensity values of  the immunofluorescent stain into numeric data. In 
tissues stained with H&E, quantification of  kidney cortex thickness was performed in a scanned whole 
kidney section, using NIS Elements (Nikon).
Real-time PCR experiments. Tissue or cell pellets were harvested and immediately snap frozen in liquid 
nitrogen. RNA from tissues was extracted per the manufacturer’s instructions, using the RNeasy Mini 
Kit (Qiagen), and 600 ng of  total RNA was reverse transcribed with iScript (Bio-Rad). Quantitative 
PCR was carried out with iQ-SYBR Green supermix (Bio-Rad) and the Bio-Rad CFX96 Real-Time 
System with the C1000 Touch Thermal Cycler, and all the reactions were done in duplicate. Cycling 
conditions were 95°C for 3 minutes, then 40 cycles of  95°C for 15 seconds, 60°C for 1 minute, followed 
by 1 cycle of  95°C for 10 seconds. Data were analyzed using the 2–ΔΔCt method. The following primers 
were used: GAPDH forward 5′-AGCCACATCGCTCAGACAC-3′ and reverse 5′-GCCCAATACGAC-
CAAATCC-3′; αSMA forward 5′-CTGACAGAGGCACCACTGAA-3′ and reverse 5′-CATCTCCA-
GAGTCCAGCACA-3′; Col1α1 forward 5′-TGACTGGAAGAGCGGAGAGT-3′ and reverse 5′-GTTC-
GGGCTGATGTACCAGT-3′; IL-6 forward 5′-CTTCACAAGTCGG AGGCTTAAT-3′ and reverse 
5′-GCAAGTG CATCATCGTTGTTC-3′; TNF-α forward 5′-CTATGTCTCAGCCTCTTCTCATTC-3′ 
and reverse 5′-GAGGCCATTTGGGAACTTCT-3′; IFN-γ forward 5′-TGAACGCTACACACTG-
CATCTTGG-3′ and reverse 5′-CGACTCCTTTTCCGCTTCCTGAG-3′; LTβr forward 5′-TGGT-
GCTCATCCCTACCTTCA-3′ and reverse 5′-TTCTCTCTATCCTCTCCCCCAG-3′; IL-1β forward 
5′-CCTTCCAGGATGAGGACATGA-3′ and reverse 5′-AACGTCACACACCAGCAGGTT-3′; F4/80 
forward 5′-CCCCAGTGTCCTTACAGAGTG-3′ and reverse 5′-GTGCCCAGAGTGGATGTCT-3′; 
CCL19 forward 5′-TGTGTTCACCACACTAAGGGG-3′ and reverse 5′-CCTTTGTTCTTGG-
CAGAAGACT-3′; PDPN forward 5′-CTCAAGCTTCAAGATGTGGACCGTGCCAGT-3′ and reverse 
5′-GAGGAATTCGGGCGAGAACCTTCCAGAAAT-3′; FN forward 5′-CGAGGTGACAGAGAC-
CACAA-3′ and reverse 5′-CTGGAGTCAAGCCAGACACA-3′.
Flow cytometry. KLNs were placed in 600 μl of  a digestion mix containing collagenase P (0.2 mg/ml), 
dispase II (0.8 mg/ml), and DNAse I (0.1 mg/ml) dissolved in Dulbecco’s PBS. After multiple rounds of  
digestion, the KLNs were dissolved entirely. Kidneys were minced, digested in collagenase P (0.25 mg/ml) 
for 30 minutes at 37°C, and filtered through a 70-μm cell strainer. The pooled digested cells were centri-
fuged, resuspended in DMEM, and counted manually utilizing 0.4% trypan blue (ThermoFisher Scientific) 
to exclude dead cells. The cell suspension was placed in 96-well round-bottom plates for intracellular cyto-
kine staining and for surface staining.
These cells were washed and stained according to standard protocols, and flow cytometry was per-
formed via BD FACSCanto II flow cytometer (BD Biosciences). Results were analyzed using FlowJo 
software (FlowJo LLC).
Electron microscopy. KLNs were fixed in Karnovsky fixative. Samples were cut into approximately 
1.5-mm-thick pieces, subjected to a secondary fixation for 1 hour in 1% osmium tetroxide/0.3% potassium 
ferrocyanide in cacodylate buffer on ice, and stained en bloc for 1 hour with 2% aqueous uranyl acetate. 
Samples were cured in an oven at 60°C for 48 hours. Sections (70 nm) were then taken and imaged on an 
FE-SEM (Zeiss Crossbeam 540) using the aSTEM detector.
FRC isolation and expansion. Murine LNs were harvested, digested with 3 ml of  enzyme mix containing 
0.2 mg/ml collagenase P, 0.1 mg/ml DNase I, and 0.8 mg/ml dispase II, and incubated at 37°C for 15 min-
utes. LNs were agitated, and the supernatant was collected. The enzyme mix was replaced, and the above 
steps were repeated until all of  the LNs were completely digested. The single-cell suspensions were cultured 
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in complete DMEM containing 10% FBS, 1% penicillin/streptomycin, and 1% L-glutamine. The complete 
DMEM was replaced after 48 hours, and FRCs were allowed to expand for 3 to 4 passages before use. Cells 
were washed twice with PBS and harvested using 0.25% trypsin-EDTA (Gibco).
Podocytes. Podocytes were a gift from Anna Greka (Brigham and Women’s Hospital).
Senescence-associated β-galactosidase staining. FRCs were seeded on glass coverslips using 6-well plates. The 
cells were allowed to attach to coverslips 1 day prior to staining. Then, they were fixed and stained according to 
the manufacturer’s protocol (Senescence β-Galactosidase staining kit, Cell Signaling Technology, catalog 9860).
Adoptive transfer of  T cells. T cells were isolated from splenocytes of  either WT mice or LTα–/– mice by 
positive selection using magnetic beads (Pan T Cell Isolation Kit, Miltenyi Biotec). Cells (2.0 × 107) were 
injected into Rag1–/– mice 1 day prior to bilateral IRI. Mice were sacrificed 2 days following IRI, and chang-
es in the KLN and kidney were assessed.
FRC labeling and injection into mice. Poly (lactic co-glycolic acid) (PLGA, 50:50 LA/GA [w/w]) NPs 
were fabricated and loaded with IR800 CW, a near-infrared fluorescent dye, using a nanoprecipitation and 
solvent evaporation method. The average diameter of  IR800-NPs was 60 nm, as measured by dynamic 
light scattering and transmission electron microscopy. Next, FRCs were incubated with IR800-NPs at 37°C 
for 1 hour and washed via centrifugation. IR800-NP–labeled FRCs (150,000 cells/mouse) were injected 
intravenously into mice. Kidneys and KLNs were harvested 16 hours after injection and imaged by a UVP 
iBox Explorer imaging microscope.
Statistics. Data are presented as mean ± SEM. Statistical analysis was performed using the unpaired 
2-tailed Student’s t test to determine differences between 2 groups and analysis of  variance to compare data 
among groups. P values of  less than 0.05 were considered statistically significant. Each experiment was 
repeated at least twice with similar results.
Study approval. All experiments were performed according to the animal experimental guidelines upon 
the approval of  the Institutional Animal Care and Use Committee at Brigham and Women’s Hospital and 
Harvard Medical School (Boston, MA).
Data availability. All data generated or analyzed during this study are available from the corresponding 
author on reasonable request.
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